No Data
No Data
Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences
WEST LAFAYETTE, Ind., May 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development
12 Health Care Stocks Moving In Monday's After-Market Session
GainersLarimar Therapeutics (NASDAQ:LRMR) stock increased by 23.6% to $8.99 during Monday's after-market session. The company's market cap stands at $573.5 million. GT Biopharma (NASDAQ:GTBP) stock ro
Inotiv Cut to Hold From Buy by Lake Street
Inotiv Cut to Hold From Buy by Lake Street
Lake Street Downgrades Inotiv to Hold, Lowers Price Target to $2
Lake Street analyst Frank Takkinen downgrades Inotiv (NASDAQ:NOTV) from Buy to Hold and lowers the price target from $10 to $2.
Inotiv Price Target Cut to $10.00/Share From $25.00 by Craig-Hallum
Inotiv Price Target Cut to $10.00/Share From $25.00 by Craig-Hallum
Inotiv Is Maintained at Buy by Craig-Hallum
Inotiv Is Maintained at Buy by Craig-Hallum
No Data